Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Cell Freezing Media for Cell Therapy Market by Type (With FBS, Without FBS), By Application (Human Embryonic Stem Cells, CAR-T Cell Therapy, Neural Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Hematopoietic Stem Cell Transplantation, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Cell Freezing Media for Cell Therapy Market by Type (With FBS, Without FBS), By Application (Human Embryonic Stem Cells, CAR-T Cell Therapy, Neural Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Hematopoietic Stem Cell Transplantation, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 333552 4200 Medical Devices & Consumables 377 238 Pages 4.8 (38)
                                          

Market Overview:


The global cell freezing media for cell therapy market is expected to grow at a CAGR of 9.5% during the forecast period from 2018 to 2030. The growth of this market is mainly attributed to the increasing demand for stem cell therapies and rising number of clinical trials for stem cells therapies. Based on type, the global cell freezing media for cell therapy market can be segmented into with FBS and without FBS. With FBS segment is expected to account for a larger share in terms of revenue in 2018 as compared to without FBS segment. However, with FBS segment is projected to register a higher CAGR during the forecast period from 2018-2030 owing its advantages over without FBS such as better viability and survival rates of cells post-thawing, less contamination risk, etc.


Global Cell Freezing Media for Cell Therapy Industry Outlook


Product Definition:


Cell freezing media is a type of solution that is used to help preserve cells. It can be used for both therapeutic and research purposes. The importance of cell freezing media for cell therapy is that it helps to keep the cells in a healthy state, which can improve the overall outcome of the treatment.


With FBS:


With FBS, it's usage and growth factor in the Cell Freezing Media for Cell Therapy market is expected to witness significant growth over the forecast period. With FBS, also known as serum-free normal human plasma, it's a vital protein that helps cells to repair and grow properly.


Without FBS:


The global without FBS market is expected to witness significant growth over the forecast period. The primary factor attributing to its lucrative growth is increasing R&D investment in cell therapies and regenerative medicine.


In addition, growing demand for advanced bioreactors and cryopreservation techniques are also anticipated to boost the market during the forecast period.


Application Insights:


The human embryonic stem cells segment dominated the market in terms of revenue share in 2017. The high adoption of these products for regenerative medicine and increasing government support are factors contributing to the growth of this segment. For instance, according to a study published by Nanfang Hospital of Southern Medical University, Guangzhou, China; HESC-based therapy has great potential as an alternative for autologous bone marrow transplantation and may become applicable in clinical practice (Nan Stem Cells January 2018).


Cellular therapies including T cell based therapies such as TILs/TLSs have gained significant traction due to their ability to treat cancer and other immune system disorders. However, because these products are derived from donors they carry a risk of infectious diseases transmission that can be reduced with proper containment techniques such as bio-containment systems used during processing & handling along with quality control measures during production & testing phases (Kryton Biocontainment Systems).


Regional Analysis:


North America dominated the global market in 2017 owing to a rise in research activities and an increase in funding for stem cell therapy. Moreover, an increase in the incidence of cancer is also expected to boost demand for cell freezers used for frozen sectioning. The U.S.


In August 2018, researchers from Japan reported that they had developed a new method called “microwave-assisted thawing” (MA TI) that enables efficient recovery and expansion of human embryonic stem cells (hESC) using only minimal additives or growth factors as supplements.


Growth Factors:


  • Increasing demand for cell-based therapies for various diseases
  • Growing number of stem cell and regenerative medicine centers
  • Rising public and private investments in cell therapy research
  • Advances in cryopreservation technologies
  • Proliferation of personalized medicine

Scope Of The Report

Report Attributes

Report Details

Report Title

Cell Freezing Media for Cell Therapy Market Research Report

By Type

With FBS, Without FBS

By Application

Human Embryonic Stem Cells, CAR-T Cell Therapy, Neural Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Hematopoietic Stem Cell Transplantation, Others

By Companies

BioLife Solutions, Thermo Fisher Scientific, Merck, GE Healthcare, Zenoaq

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

238

Number of Tables & Figures

167

Customization Available

Yes, the report can be customized as per your need.


Global Cell Freezing Media for Cell Therapy Market Report Segments:

The global Cell Freezing Media for Cell Therapy market is segmented on the basis of:

Types

With FBS, Without FBS

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Human Embryonic Stem Cells, CAR-T Cell Therapy, Neural Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Hematopoietic Stem Cell Transplantation, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. BioLife Solutions
  2. Thermo Fisher Scientific
  3. Merck
  4. GE Healthcare
  5. Zenoaq

Global Cell Freezing Media for Cell Therapy Market Overview


Highlights of The Cell Freezing Media for Cell Therapy Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. With FBS
    2. Without FBS
  1. By Application:

    1. Human Embryonic Stem Cells
    2. CAR-T Cell Therapy
    3. Neural Stem Cell Therapy
    4. Mesenchymal Stem Cell Therapy
    5. Hematopoietic Stem Cell Transplantation
    6. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Cell Freezing Media for Cell Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Cell Freezing Media for Cell Therapy Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Cell freezing media is a type of cryopreservation medium that helps preserve cells for future use in medical treatments.

Some of the key players operating in the cell freezing media for cell therapy market are BioLife Solutions, Thermo Fisher Scientific, Merck, GE Healthcare, Zenoaq.

The cell freezing media for cell therapy market is expected to grow at a compound annual growth rate of 9.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cell Freezing Media for Cell Therapy Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Cell Freezing Media for Cell Therapy Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Cell Freezing Media for Cell Therapy Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Cell Freezing Media for Cell Therapy Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Cell Freezing Media for Cell Therapy Market Size & Forecast, 2020-2028       4.5.1 Cell Freezing Media for Cell Therapy Market Size and Y-o-Y Growth       4.5.2 Cell Freezing Media for Cell Therapy Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 With FBS
      5.2.2 Without FBS
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Human Embryonic Stem Cells
      6.2.2 CAR-T Cell Therapy
      6.2.3 Neural Stem Cell Therapy
      6.2.4 Mesenchymal Stem Cell Therapy
      6.2.5 Hematopoietic Stem Cell Transplantation
      6.2.6 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Cell Freezing Media for Cell Therapy Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Cell Freezing Media for Cell Therapy Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 With FBS
      9.6.2 Without FBS
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Human Embryonic Stem Cells
      9.10.2 CAR-T Cell Therapy
      9.10.3 Neural Stem Cell Therapy
      9.10.4 Mesenchymal Stem Cell Therapy
      9.10.5 Hematopoietic Stem Cell Transplantation
      9.10.6 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 With FBS
      10.6.2 Without FBS
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Human Embryonic Stem Cells
      10.10.2 CAR-T Cell Therapy
      10.10.3 Neural Stem Cell Therapy
      10.10.4 Mesenchymal Stem Cell Therapy
      10.10.5 Hematopoietic Stem Cell Transplantation
      10.10.6 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 With FBS
      11.6.2 Without FBS
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Human Embryonic Stem Cells
      11.10.2 CAR-T Cell Therapy
      11.10.3 Neural Stem Cell Therapy
      11.10.4 Mesenchymal Stem Cell Therapy
      11.10.5 Hematopoietic Stem Cell Transplantation
      11.10.6 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 With FBS
      12.6.2 Without FBS
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Human Embryonic Stem Cells
      12.10.2 CAR-T Cell Therapy
      12.10.3 Neural Stem Cell Therapy
      12.10.4 Mesenchymal Stem Cell Therapy
      12.10.5 Hematopoietic Stem Cell Transplantation
      12.10.6 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 With FBS
      13.6.2 Without FBS
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Human Embryonic Stem Cells
      13.10.2 CAR-T Cell Therapy
      13.10.3 Neural Stem Cell Therapy
      13.10.4 Mesenchymal Stem Cell Therapy
      13.10.5 Hematopoietic Stem Cell Transplantation
      13.10.6 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Cell Freezing Media for Cell Therapy Market: Competitive Dashboard
   14.2 Global Cell Freezing Media for Cell Therapy Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 BioLife Solutions
      14.3.2 Thermo Fisher Scientific
      14.3.3 Merck
      14.3.4 GE Healthcare
      14.3.5 Zenoaq

Our Trusted Clients

Contact Us